---
reference_id: "PMID:16322474"
title: Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
authors:
- Hassenpflug WA
- Budde U
- Obser T
- Angerhaus D
- Drewke E
- Schneppenheim S
- Schneppenheim R
journal: Blood
year: '2006'
doi: 10.1182/blood-2005-04-1758
content_type: abstract_only
---

# Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
**Authors:** Hassenpflug WA, Budde U, Obser T, Angerhaus D, Drewke E, Schneppenheim S, Schneppenheim R
**Journal:** Blood (2006)
**DOI:** [10.1182/blood-2005-04-1758](https://doi.org/10.1182/blood-2005-04-1758)

## Content

1. Blood. 2006 Mar 15;107(6):2339-45. doi: 10.1182/blood-2005-04-1758. Epub 2005 
Dec 1.

Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent 
proteolysis.

Hassenpflug WA(1), Budde U, Obser T, Angerhaus D, Drewke E, Schneppenheim S, 
Schneppenheim R.

Author information:
(1)Dept of Pediatric Hematology and Oncology, University Medical Center 
Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.

Classical von Willebrand disease (VWD) type 2A, the most common qualitative 
defect of VWD, is caused by loss of high-molecular-weight multimers (HMWMs) of 
von Willebrand factor (VWF). Underlying mutations cluster in the A2 domain of 
VWF around its cleavage site for ADAMTS13. We investigated the impact of 
mutations commonly found in patients with VWD type 2A on ADAMTS13-dependent 
proteolysis of VWF. We used recombinant human ADAMTS13 (rhuADAMTS13) to digest 
recombinant full-length VWF and a VWF fragment spanning the VWF A1 through A3 
domains, harboring 13 different VWD type 2A mutations (C1272S, G1505E, G1505R, 
S1506L, M1528V, R1569del, R1597W, V1607D, G1609R, I1628T, G1629E, G1631D, and 
E1638K). With the exception of G1505E and I1628T, all mutations in the VWF A2 
domain increased specific proteolysis of VWF independent of the expression 
level. Proteolytic susceptibility of mutant VWF in vitro closely correlated with 
the in vivo phenotype in patients. The results imply that increased VWF 
susceptibility for ADAMTS13 is a constitutive property of classical VWD type 2A, 
thus explaining the pronounced proteolytic fragments and loss of HMWM seen in 
multimer analysis in patients.

DOI: 10.1182/blood-2005-04-1758
PMID: 16322474 [Indexed for MEDLINE]